Security company ClearDATA raises $25 mln

Phoenix-based ClearDATA, a provider of security services for the healthcare industry, announced it has raised an over-subscribed $25 million Series C round of funding. Investors include Heritage Group, HLM Venture Partners and Flare Capital Partners, along with existing investors Norwest Venture Partners, Merck Global Health Innovation Fund and Excel Venture Management. The company has now raised $42.4 million to date.


Merck Global Health Innovation Fund backs Liaison Technologies

Merck Global Health Innovation Fund has made an undisclosed investment in Liaison Technologies. According to Liaison, this investment brings the company’s total funding to over $90 million. With offices in the U.S., Finland, Netherlands, Sweden and the UK, Liaison is a provider of data integration and data management solutions.


Aventura picks up $14 mln Series C

Denver-based Aventura, a provider of healthcare workflow optimization software solutions, has secured $14 million in Series C funding. Safeguard Scientifics and Merck Global Health Innovation Fund led the round with participation from previous backers Excel Venture Management, HLM Venture Partners and Memorial Care Innovation Fund.


WiserTogether nets $9 mln

WiserTogether, a healthcare treatment comparison software firm, said Wednesday that it has closed $9 million in Series B funding. Martin Ventures and Merck Global Health Innovation Fund led the round with participation from other investors that included Grotech Ventures, Harbert Venture Partners, 7Wire Ventures and Blue Heron Capital.


Healthsense nabs $10 mln

Healthsense said Tuesday that it has raised $10 million in financing. Mansa Capital led the round with participation from return backers Merck Global Health Innovation Fund and Radius Ventures. Heathsense is a provider of tech-enabled care solutions for the senior care continuum.


electroCore raises $50 mln from investor group

electroCore, which has developed non-invasive therapy for treatment of conditions in neurology, psychiatry, gastroenterology, among others, has raised $50 million from investors including Merck’s Global Health Innovation Fund, Easton Capital and Core Ventures. electroCore’s primary focus at present is cluster and migraine headaches.


MedCPU closes $9.3 mln Series B funding

MedCPU, Inc., which provides real-time clinical decision support services, has closed a $9.3 million Series B funding. Investors in the funding round include Merck Global Health Innovation Fund, Easton Capital Investment Group and New Richmond Ventures.

AdvanDx raises $12mln for expansion

AdvanDx has closed a $12 million financing led by Merck Global Health Innovation Fund with participation from existing investors SLS Ventures AB and LD Pensions. The Series B-1 financing will be used to fund the expansion of AdvanDx’s molecular diagnostic product offerings, as well as its sales and marketing presence in the US and internationally.

superhero businessman shutterstock_95792629
2629 Views 2 Comments

Next-generation corporate VCs are here to stay

There are three main reasons why next-generation corporate VCs who are practicing today are fundamentally different from their predecessors, and why they will be a driving force in the venture industry for many years to come, says guest columnist William Taranto, president of Merck Global Health Innovation Fund.

Medivo Raises $15 Million to Expand Health Monitoring Platform

Medivo, a New York-based online health monitoring platform, has raised $15 million in Series B financing led by the Merck Global Health Innovation Fund, with participation from existing investors Safeguard Scientifics and MentorTech Ventures. To date, the company has raised more than $22 million.

Daktari Diagnostics Inks $10M

Cambridge, Mass.-based Daktari Diagnostics Inc. has raised $10 million in a staged financing round, the company announced recently. The financing for Daktari—which makes point-of-care diagnostic systems for the developing world—was led by Merck Global Health Innovation Fund. Norwich Ventures and the Partners Innovation Fund also contributed. The money will help complete development and bring to market the company’s initial products, intended for use in monitoring HIV patients worldwide.

Aviir Seals Agreement for Up to $30M in Funding

Irvine, Calif.-based biotech company Aviir Inc. announced Tuesday that it had sealed an agreement with investors to raise up to $30 million. The financing includes an initial investment of $10 million and future investments of up to $20 million upon achieving certain milestones. Merck Global Health Innovation Fund led the round. Current investors Bay City Capital, Aberdare Ventures, and New Leaf Venture Partners also participated.

PE HUB Community

Join the 12522 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget